Flavor inhaler and flavor inhalation system

The flavor inhaler addresses the lack of control over capsule position by using a contact member that moves to specific positions for capsule destruction, enhancing aerosol generation consistency and user experience.

WO2024241453A1PCT designated stage expired Publication Date: 2024-11-28JAPAN TOBACCO INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2023/019029
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-22
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing flavor inhalers lack control over the position of the contact member after breaking the capsule, which affects the consistency and efficiency of aerosol generation.

Method used

A flavor inhaler with a holding part and a contact member that moves from a starting position to a predetermined position to destroy the capsule, with the option to fix the contact member at various positions, including the starting, destruction, or intermediate positions, to control the capsule destruction and aerosol release.

Benefits of technology

Enables precise control over the capsule destruction and aerosol generation, improving user experience and consistency by allowing the contact member to be fixed at desired positions, facilitating easier insertion of new base materials and adjusting ventilation resistance and flavor concentration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2023019029_28112024_PF_FP_ABST
    Figure JP2023019029_28112024_PF_FP_ABST
Patent Text Reader

Abstract

A flavor inhaler 1 for generating an aerosol due to heating of a base material 500 having a capsule 504 for discharging content when ruptured and a base material part 501 includes: a holding part 140 forming a space for storing and holding the base material 500; and a rupture mechanism 30 for coming into contact with a capsule region in which the capsule 504 of the base material 500 held by the holding part 140 is placed. The rupture mechanism 30 moves to a second position for rupturing the capsule due to pressing of the capsule region from a first position for starting movement to rupture the capsule 504, and then is fixed to a predetermined position.
Need to check novelty before this filing date? Find Prior Art

Description

Flavor inhaler and flavor inhalation system

[0001] The present disclosure relates to a flavor inhaler and a flavor inhalation system.

[0002] Patent document 1 describes an apparatus for generating aerosols, comprising a heating chamber for receiving an aerosol-forming article including an aerosol-forming substrate, and a cooling chamber in fluid communication with the heating chamber and a mouthpiece end of the apparatus. Patent document 1 discloses that the apparatus comprises a flavor-releasing means or mechanism for selectively releasing an additional flavor from the aerosol-forming article received in the heating chamber, and that the flavor-releasing means or mechanism may include a clamping element operable to relatively reduce the dimensions of at least a portion of the aerosol-forming article received in the heating chamber.

[0003] Special Publication No. 2021-531026

[0004] A flavor inhaler that generates an aerosol by heating a substrate may include a contact member that moves and contacts the substrate while the substrate is inserted into the main body so as to destroy capsules in the substrate. In this case, it is desirable to control the position of the contact member that destroys the capsules. The present disclosure provides a flavor inhaler and a flavor inhalation system in which the position of the contact member after destroying the capsules in the substrate is controlled.

[0005] The present disclosure, which has been completed with respect to this object, provides a flavor inhaler that generates an aerosol by heating a substrate having an aerosol source and a capsule that releases its contents when broken. The flavor inhaler includes a holding section that forms a space for accommodating and holding the substrate, and a contact member that contacts a capsule region of the substrate held in the holding section where the capsule is located. The contact member moves from a first position where it starts moving to break the capsule to a second position where it pushes the capsule region to break the capsule, and then is fixed at a predetermined position. Here, the predetermined position may be the first position. After moving to the second position, the contact member may be fixed at the first position until a new substrate different from the substrate that the contact member contacted is held in the holding section. The predetermined position may also be the second position. The predetermined position may also be a third position located between the first position and the second position. The predetermined position may also be a third position selected by a user from a plurality of third positions. Furthermore, when the second position is a position where the displacement amount when moving from the first position is largest, the contact member may be fixed at a position between the first position and the second position when moving from the first position to the second position. Furthermore, the present disclosure, which has been completed with this object in mind, is a flavor inhalation system including the flavor inhaler and a substrate having an aerosol source and a capsule that releases its contents when broken, the substrate being heated by the flavor inhaler.

[0006] According to the present disclosure, it is possible to provide a flavor inhaler and a flavor inhalation system in which the position of a contact member is controlled after a capsule in a base material is broken.

[0007] FIG. 1 is an overall perspective view of a flavor inhaler according to a first embodiment; FIG. 2 is an example of a cross-sectional view of a flavor inhaler according to a first embodiment; FIG. 3 is a schematic diagram showing an example of the internal configuration of a main body of a flavor inhaler; FIG. 4 is a diagram showing an example of a destruction mechanism according to a first embodiment; FIG. 5 is another example of a cross-sectional view of a flavor inhaler according to a first embodiment; FIG. 6 is a diagram showing an example of a destruction mechanism according to a second embodiment; FIG. 7 is an example of a cross-sectional view of a flavor inhaler according to a second embodiment; FIG. 8 is another example of a cross-sectional view of a flavor inhaler according to a second embodiment; FIG. 9 is another example of a cross-sectional view of a flavor inhaler according to a second embodiment; FIG. 10 is a diagram showing an example of a destruction mechanism according to a third embodiment; FIG. 11 is an example of a cross-sectional view of a flavor inhaler according to a third embodiment; FIG. 12 is another example of a cross-sectional view of a flavor inhaler according to a third embodiment; FIG. 13 is an example of a cross-sectional view of a flavor inhaler according to a fourth embodiment; FIG. 14 is another example of a cross-sectional view of a flavor inhaler according to a fourth embodiment.

[0008] Hereinafter, embodiments of the present disclosure will be described in detail with reference to the accompanying drawings, in which the same parts are designated by the same reference numerals.

[0009] <First Embodiment> Fig. 1 is an overall perspective view of a flavor inhaler 1 according to the first embodiment. Fig. 2 is an example of a cross-sectional view of the flavor inhaler 1 according to the first embodiment. Note that Fig. 2 omits the internal configuration of the flavor inhaler 1, which is not normally visible to the user. The flavor inhalation system according to this embodiment includes the flavor inhaler 1 according to the first embodiment and a substrate 500 having a capsule 504 and an aerosol source and heated by the flavor inhaler 1. The flavor inhaler 1 according to the first embodiment is a non-combustion heating type and is used with the substrate 500 inserted. The flavor inhaler 1 according to the first embodiment includes a main body 100 that holds the substrate 500 having the capsule 504 and the aerosol source, and a destruction mechanism 30 that contacts a region of the substrate 500 where the capsule 504 is located (hereinafter referred to as the "capsule region"). The main body 100 includes a holder 140 that holds the substrate 500 and an insertion port 142 that connects an internal space 141 to the outside and through which the substrate 500 is inserted. The flavor inhaler 1 may also have a cover 10 that is detachable from the main body 100, and a shutter 20 that opens and closes the insertion opening 142. Hereinafter, the direction of the center line CL of the base material 500 defined by the holding part 140 may be referred to as the "center line direction." One end side in the center line direction (the right side in FIG. 2 ) may be referred to as the first side, and the other end side in the center line direction (the left side in FIG. 2 ) may be referred to as the second side. The first side is the end side that the user holds in their mouth for inhalation. The second side is the end side opposite the first side, which is the end side that is inserted into the flavor inhaler 1.

[0010] (Substrate 500) As shown in FIG. 2, the substrate 500 is a stick-shaped member. The substrate 500 includes a heated portion 501 containing an aerosol source and a capsule 504 that releases its contents when broken. The substrate 500 may also include a cooling portion 502 that cools the vapor generated by heating the heated portion 501 to promote the generation of the aerosol, and a suction port portion 503 through which the generated aerosol passes. The substrate 500 preferably deforms when a physical external force is applied, but returns to its original shape when the physical external force is no longer applied.

[0011] The heated portion 501 is a component that is heated when inserted into the flavor inhaler 1. The heated portion 501 includes an aerosol source. The aerosol source is heated to atomize it, generating an aerosol. The aerosol source may be tobacco-derived, such as a processed product obtained by molding shredded tobacco or tobacco raw materials into granules, sheets, or powder. The aerosol source may also include non-tobacco-derived aerosols made from plants other than tobacco (e.g., mint and herbs). For example, the aerosol source may contain a flavoring component such as menthol. When the flavor inhaler 1 is a medical inhaler, the aerosol source may contain a drug to be inhaled by the patient. Note that the aerosol source is not limited to a solid, but may also be a liquid such as a polyhydric alcohol such as glycerin or propylene glycol, or water. At least a portion of the heated portion 501 is accommodated in the internal space 141 of the holding portion 140 when the substrate 500 is held by the holding portion 140.

[0012] The cooling section 502 is a section formed by rolling the sheet into a tube such as a cylinder. The material of the sheet is not particularly limited and may be, for example, a sheet primarily composed of pulp, or a sheet primarily composed of any of polyethylene, polypropylene, polyvinyl chloride, polyethylene terephthalate, polylactic acid, cellulose acetate, and aluminum foil, or any combination thereof. The cooling section 502 may also be formed, for example, from a tube made of synthetic resin or the like. The size of the cooling section 502 can be appropriately changed depending on the size of the product, but a size that ensures sufficient cooling effect while obtaining a good flavor and suppresses loss of generated vapor and aerosol due to adhesion to the sheet is desirable. The cooling section 502 may have a plurality of concentric through-holes (also referred to in the art as "ventilation filters") circumferentially and concentrically present in the area that protrudes from the insertion opening 142 when the substrate 500 is held in the holding section 140 of the flavor inhaler 1.

[0013] The mouthpiece portion 503 is held in the mouth by the user when inhaling. At least a portion of the mouthpiece portion 503 protrudes from the insertion opening 142 when the substrate 500 is held in the holding portion 140. When the user holds the mouthpiece portion 503 protruding from the insertion opening 142 and inhales, the aerosol generated from the heated portion 501 and the flavor and aroma components from the capsule 504 reach the user's mouth. The mouthpiece portion 503 includes, for example, a filter material and has the general function of a filter. The filter material may be, for example, a cylindrically shaped filler such as cellulose acetate fiber, nonwoven fabric, or pulp paper, or may be a paper filter filled with sheet-like pulp paper. General filter functions include, for example, reducing unpleasant sensations such as irritation, reducing nicotine and tar, and, if openings corresponding to through-holes are present on the second side of the filter, adjusting the amount of air mixed in when inhaling the aerosol, etc., although it is not necessary for the filter to have all of these functions. Furthermore, in the substrate 500, which tends to produce fewer components and has a lower aerosol source filling rate in the heated section 501 compared to cigarette products, other important functions include preventing the aerosol source from falling off while suppressing the filtration function, and adjusting the air resistance to provide appropriate ease of inhalation.

[0014] The capsule 504 is encapsulated with a coating containing a content including a flavor component. The content of the capsule 504 may include, for example, an aerosol source, or may include only the aerosol source without the flavor component. The shape of the capsule 504 is not particularly limited and may be spherical, cylindrical, truncated conical, or the like. The capsule 504 may be disposed in a region of the substrate 500 that is contained in the internal space 141 while the substrate 500 is held by the holding unit 140, and may be disposed, for example, inside the heated unit 501. Preferably, the capsule 504 is destroyed when subjected to a physical external force by the destruction mechanism 30, but is not destroyed by collisions or pressures caused by normal vibrations, such as those associated with transportation of the substrate 500 in a vehicle or the like, carrying the substrate 500 by a user, or insertion of the substrate 500 into the flavor inhaler 1 by a user. Here, "destroyed" includes both partial destruction and complete destruction. "Partially destroyed" means that the coating is cracked or punctured to the extent that the contents are gradually released. "Completely destroyed" means that the coating is broken to the extent that the contents are released all at once. The composition of the coating of capsule 504 is not particularly limited as long as it is a composition that is destroyed when a predetermined physical external force is applied by destruction mechanism 30. Furthermore, the contents of capsule 504 include, for example, a flavor component as a flavor component. Furthermore, the contents of capsule 504 may include, for example, a taste component as a flavor component.

[0015] (Flavor inhaler 1) FIG. 3 is a schematic diagram showing an example of the internal configuration of the main body 100 of the flavor inhaler 1. Note that the destruction mechanism 30 is omitted in FIG. 3. The main body 100 of the flavor inhaler 1 includes a power supply unit 131 that stores power and supplies power to each component of the main body 100, a sensor unit 132 that detects various information related to the main body 100, and a notification unit 133 that notifies the user of the information. The main body 100 also includes a memory unit 134 that stores various information for the operation of the main body 100, a communication unit 135 that transmits and receives information between the main body 100 and other devices, and a control unit 136 that controls the overall operation of the main body 100. The main body 100 also includes a heating unit 121 that heats the substrate 500 and a heat insulating unit 144 that prevents heat transfer from the heating unit 121 to other components of the main body 100. In the flavor inhaler 1, the user inhales with the substrate 500 held in the holding unit 140.

[0016] The heating unit 121 heats the heated portion 501 of the substrate 500. The heating unit 121 is made of any material, such as metal or polyimide. For example, the heating unit 121 is configured in a film shape and is arranged to cover the outer periphery of the holding unit 140. When the heating unit 121 generates heat, the aerosol source included in the heated portion 501 of the substrate 500 is heated from the outer periphery of the substrate 500. The heating unit 121 generates heat when power is supplied from the power supply unit 131. As an example, power may be supplied when the sensor unit 132 detects that a predetermined user input has been made. When the temperature of the substrate 500 heated by the heating unit 121 reaches a predetermined temperature, the user can inhale. Thereafter, when the sensor unit 132 detects that a predetermined user input has been made, power supply may be stopped. As another example, power may be supplied and aerosol may be generated during a period in which the sensor unit 132 detects that the user has inhaled.

[0017] The heat insulating section 144 is disposed so as to cover at least the outer periphery of the heating section 121. For example, the heat insulating section 144 is made of a vacuum heat insulating material, an aerogel heat insulating material, or the like. Note that the vacuum heat insulating material is a heat insulating material in which, for example, glass wool, silica (silicon powder), or the like is wrapped in a resin film to create a high vacuum state, thereby reducing the heat conduction by gas to as close to zero as possible.

[0018] The holding unit 140 forms a space that accommodates and holds the substrate 500. The holding unit 140 has a columnar internal space 141 provided inside the main body 100 and an insertion port 142 formed to connect the internal space 141 to the outside. The internal space 141 is, for example, a cylindrical body. The holding unit 140 is configured so that the inner diameter of the cylindrical body is smaller than the outer diameter of the substrate 500 in at least a portion of the height direction, and can hold the substrate 500 by compressing the substrate 500 inserted into the internal space 141 from the insertion port 142 from the outer periphery. The holding unit 140 also has the function of defining an air flow path that passes through the substrate 500.

[0019] 1 shows the shutter 20 closing the insertion opening 142. The shutter 20 has a sliding mechanism and is movable along the surface of the outer shell between a position where the insertion opening 142 is closed and a position where the insertion opening 142 is open. The insertion opening 142 is opened when the user places their finger on the shutter 20 and slides it along the side. As a result of the insertion opening 142 being opened, the user inserts the substrate 500 into the holder 140, as shown in FIG.

[0020] ((Destruction Mechanism 30)) FIG. 4 is a diagram showing an example of the destruction mechanism 30 according to the first embodiment. FIG. 5 is a cross-sectional view of another example of the flavor inhaler 1 according to the first embodiment. The destruction mechanism 30 is a mechanism that presses the capsule region of the base material 500 and destroys the capsules 504 arranged in the base material 500.

[0021] The destruction mechanism 30 includes, for example, a pusher 31 pushed by the user, a spring 32 that urges the pusher 31 out of the flavor inhaler 1, and a contact member 33 that contacts the capsule region. The pusher 31 has a shape that allows it to move inside the flavor inhaler 1 and to push the spring 32 into the flavor inhaler 1. In the example shown in FIG. 4 , the pusher 31 moves inside the flavor inhaler 1 with a portion of it inside the spring 32, thereby pushing the spring 32 into the flavor inhaler 1. The spring 32 is a member that expands and contracts in a direction perpendicular to the centerline direction (hereinafter referred to as the "orthogonal direction") and is bonded to the pusher 31 and the contact member 33. In the example shown in FIG. 4 , the spring 32 is a so-called compression coil. The contact member 33 is a member that moves into the internal space 141 when the pusher 31 is pressed. 4, the contact member 33 has a flat plate-like shape, but the surface that contacts the capsule region may be raised or needle-like. The weight of the pushing member 31 and the contact member 33 is such that they can move in accordance with the expansion and contraction of the spring 32. In the state shown in FIG. 5, the pushing member 31 and the contact member 33 are fixed by a protrusion (not shown) made of, for example, an elastic material and provided on the main body 100.

[0022] The destruction mechanism 30 moves the contact member 33 in the orthogonal direction depending on whether or not the user pushes the pushing member 31 into the flavor inhaler 1. The destruction mechanism 30 also moves the contact member 33 to a position where it will destroy the capsule, and then fixes it at a predetermined position. Examples of predetermined positions include a start position where movement to destroy the capsule 504 begins, a destruction position where destruction of the capsule 504 is completed, and an intermediate position between the destruction position and the start position. The "start position" refers to a position where the user does not perform a pushing operation. The "destruction position" refers to a position where the contact member 33 is pushed to the deepest point in the internal space 141 by the user's pushing operation. In other words, the "destruction position" refers to a position where the displacement (movement) of the contact member 33 is greatest when it moves from the start position toward the internal space 141.

[0023] When pressed by a user, the pressing member 31 moves from the start position shown in Fig. 2 toward the inside of the flavor inhaler 1 as shown in Fig. 5. The pressing member 31 may be movable to a breaking position where the capsule 504 is broken by the contact member 33, but preferably is movable to a position where the entire capsule 504 is broken by the contact member 33. In other words, the contact member 33, which is positioned adjacent to the internal space 141 and movable into the internal space 141, moves from the start position shown in Fig. 2 into the internal space 141 as shown in Fig. 5 when the pressing member 31 is pressed by a user. The contact member 33 may be movable to a breaking position, but preferably is movable to a position where the entire capsule 504 is broken by the contact member 33. The start position is an example of a first position, and the breaking position is an example of a second position.

[0024] When the contact member 33 moves into the internal space 141, it applies a physical external force to at least a portion of the capsule region. Specifically, the contact member 33, which has moved into the internal space 141 as a result of the user pressing the push member 31, indirectly applies pressure to the capsule 504. The magnitude of this pressure is affected by the degree of pressing of the push member 31. The degree of pressing of the push member 31 can be adjusted based on the force applied by the user. Note that if the contact member 33 has a needle shape, the contact member 33, which has moved into the internal space 141 as a result of the user pressing the push member 31, may penetrate the base material 500 and come into direct contact with the capsule 504, thereby destroying the capsule 504.

[0025] When the user releases the pressure on the pressing member 31, the pressing member 31 moves to the start position due to the biasing force of the spring 32. Furthermore, when the shape of the substrate 500 returns to its original shape after the external physical force is no longer applied, the contact member 33 also moves toward the start position. Specifically, the contact member 33 moves from the start position to the breaking position and then returns to the start position. In other words, the contact member 33 moves from the start position to the breaking position and then is fixed at the start position. The contact member 33 is fixed at the start position until a new substrate 500 different from the substrate 500 whose capsule 504 has been broken by the breaking mechanism 30 is held in the holding unit 140. Furthermore, it is more preferable that the contact member 33 be fixed at the start position until the substrate 500 whose capsule 504 has been broken by the breaking mechanism 30 is removed from the flavor inhaler 1 by the user.

[0026] The breaking mechanism 30 may have a mechanism for storing the portion of the pushing member 31 that protrudes from the flavor inhaler 1 when the contact member 33 is in the starting position. For example, the breaking mechanism 30 may have a mechanism that can bend the pushing member 31 so that the portion of the pushing member 31 that protrudes from the flavor inhaler 1 is aligned with the flavor inhaler 1 when the contact member 33 is in the starting position.

[0027] As described above, the flavor inhaler 1 is a flavor inhaler that generates an aerosol by heating a substrate 500 having an aerosol source and a capsule 504 that releases its contents when broken, and includes a holding part 140 that forms an internal space 141 that accommodates and holds the substrate 500, and a destruction mechanism 30 that comes into contact with a capsule region in which the capsules 504 are located in the substrate 500 held in the holding part 140. The destruction mechanism 30 pushes the capsule region from a start position where it starts moving to break the capsule 504, and moves to a breaking position where it breaks the capsule 504, and is then fixed at a predetermined position.

[0028] The destruction mechanism 30 includes, for example, a pusher 31, a spring 32, and a contact member 33. When the pusher 31 is pressed by the user, the contact member 33 is moved into the internal space 141, and pressure is indirectly applied to the capsules 504. When the user no longer presses the pusher 31, the pusher 31 is moved to the start position by the biasing force of the spring 32, and as the shape of the substrate 500 returns to its original shape, the contact member 33 is also moved to the start position. In other words, the contact member 33 of the destruction mechanism 30 moves from the start position to the destruction position and is then fixed at the start position. This makes it possible to control the position of the contact member 33 after destroying the capsules 504 in the substrate 500.

[0029] After the contact member 33 moves to the destruction position, the contact member 33 may be fixed at the start position until a new substrate 500 different from the substrate 500 that the contact member 33 contacted is held in the holding part 140. Fixing the contact member 33 at the start position makes it easier for the user to insert the new substrate 500 into the flavor inhaler 1.

[0030] Second Embodiment FIG. 6 is a diagram showing an example of a destruction mechanism 230 according to the second embodiment. FIG. 7 is an example of a cross-sectional view of the flavor inhaler 2 according to the second embodiment. FIG. 8 is another example of a cross-sectional view of the flavor inhaler 2 according to the second embodiment. FIG. 9 is another example of a cross-sectional view of the flavor inhaler 2 according to the second embodiment. Note that the internal structure of the flavor inhaler 2, which is not normally visible to the user, is omitted from FIGS. 7, 8, and 9. FIG. 7 shows the contact member 237 shown in FIG. 6 in the start position, and FIG. 8 shows the contact member 237 in the destruction position. FIG. 9 shows the contact member 237 in the intermediate position. The flavor inhaler 2 according to the second embodiment differs from the flavor inhaler 1 according to the first embodiment in that the destruction mechanism 230 corresponds to the destruction mechanism 30. Differences from the first embodiment will be described below. The same components in the first and second embodiments are designated by the same reference numerals, and detailed descriptions thereof will be omitted.

[0031] 6 differs from the destruction mechanism 30 shown in Fig. 4 in that the destruction mechanism 230 extends in an orthogonal direction so as to press the capsule region of the substrate 500, and destroys the capsules 504 arranged in the substrate 500. Specifically, the destruction mechanism 230 is a knock mechanism that moves the contact member 237 into the internal space 141 by a knock operation, which is an operation in which the user temporarily presses the push member 231.

[0032] The destruction mechanism 230 includes, for example, a pusher 231 pushed by the user, an adjustment member 232 that adjusts the movement of the pusher 231 as it is pushed, a first spring 233 that urges the adjustment member 232 toward the outside of the flavor inhaler 1, a rotor 234 that enters a groove on the outer circumferential surface of the adjustment member 232 and controls the rotation of a cam 235, the rotating cam 235, a second spring 236 that urges the cam 235 toward the outside of the flavor inhaler 1, and a contact member 237 that contacts the capsule region. To prevent the pusher 231 from falling off the flavor inhaler 1, for example, a restricting protrusion (not shown) provided on the outer circumferential surface of the pusher 231 is accommodated in a restricting groove (not shown) provided on the inner circumferential surface of the adjustment member 232. The first spring 233 is provided on a portion of the outer circumferential surface of the adjustment member 232 where the rotor 234 is not present. The second spring 236 is provided on the outer peripheral surface of the contact member 237 and does not move inside the cam 235 or into the internal space 141. If the contact member 237 is needle-shaped, the contact member 237 may move into the internal space 141, penetrate the base material 500, and come into direct contact with the capsule 504, thereby destroying the capsule 504. The destruction mechanism 230 may also have a mechanism for storing the portion of the pushing member 231 that protrudes from the flavor inhaler 1 when the contact member 237 is in the starting position.

[0033] The pushing member 231 can move toward the inside of the flavor inhaler 1. When the pushing member 231 is knocked by the user, the cam 235 rotates. Then, the rotor 234 comes into contact with a location different from the location where it contacted the cam 235 in the state shown in FIG. 7 , and the rotation of the cam 235 stops. The contact member 237 is maintained in a state in which it has moved from the start position shown in FIG. 7 into the internal space 141 as shown in FIG. 8 . Specifically, the contact member 237 moves from the start position to the breaking position and is then fixed at the breaking position. Furthermore, when the pushing member 231 is knocked again by the user, the cam 235 rotates. Then, the rotor 234 comes into contact with a location different from the location where it contacted the cam 235 in the state shown in FIG. 8 , and the rotation of the cam 235 stops. The contact member 237 returns from the breaking position shown in FIG. 8 to, for example, the start position shown in FIG. 7 and is fixed there.

[0034] The contact member 237, which moves into the internal space 141 in conjunction with the user's knocking operation of the push member 231, indirectly applies pressure to the capsule 504. The magnitude of this pressure is affected by the location of the cam 235 with which the rotor 234 comes into contact. Specifically, the magnitude of this pressure is affected by the depth of the groove of the cam 235 in which the rotor 234 is housed.

[0035] The position at which the contact member 237 is fixed is not limited to the start position or the destruction position, but may be fixed at an intermediate position between the destruction position and the start position. For example, the depth of the groove of the cam 235 may be varied so that the contact member 237 is fixed at an intermediate position depending on the location where the rotor 234 contacts the cam 235. Furthermore, the number of intermediate positions is not limited to one, and there may be multiple intermediate positions. The intermediate position is an example of a third position.

[0036] When the user knocks the pressing member 231 while the contact member 237 is fixed in the breaking position, the contact member 237 may be moved from the breaking position shown in FIG. 8 to the intermediate position shown in FIG. 9 and maintained therein. Specifically, the contact member 237 may be moved from the start position to the breaking position and then fixed at the intermediate position. Furthermore, if there are multiple positions that can be fixed as intermediate positions, the contact member 237 may be fixed at an intermediate position selected by the user from among the multiple intermediate positions. For example, when the user knocks the pressing member 231 once while the contact member 237 is fixed in the breaking position, the contact member 237 moves to a position between the breaking position shown in FIG. 8 and the position shown in FIG. 9. Then, when the user knocks the pressing member 231 once again, the contact member 237 may be moved to and maintained at the position shown in FIG. 9.

[0037] Furthermore, when the user knocks the pressing member 231 while the contact member 237 is fixed at the start position, the contact member 237 may be moved from the breaking position shown in Fig. 7 to the intermediate position shown in Fig. 9 and maintained in that state. Specifically, the contact member 237 may be fixed at the intermediate position midway during the movement from the start position to the breaking position.

[0038] As described above, the flavor inhaler 2 is a flavor inhaler that generates an aerosol by heating a substrate 500 having an aerosol source and a capsule 504 that releases its contents when broken, and includes a holding part 140 that forms an internal space 141 that accommodates and holds the substrate 500, and a destruction mechanism 230 that contacts a capsule region of the substrate 500 held in the holding part 140 where the capsules 504 are located. The destruction mechanism 230 pushes the capsule region from a start position where it starts moving to destroy the capsules 504, moves to a destruction position where it destroys the capsules 504, and is then fixed at a predetermined position. As with the flavor inhaler 1, the flavor inhaler 2 can control the position of the contact member 237 after destroying the capsules 504 in the substrate 500.

[0039] The destruction mechanism 230 is a knock mechanism that moves the contact member 237 into the internal space 141 when the user knocks the push member 231, for example. When the user knocks the push member 231, the contact member 237 moves into the internal space 141, and pressure is indirectly applied to the capsule 504. The contact member 237 is maintained in a state moved into the internal space 141. In other words, the contact member 237 of the destruction mechanism 230 moves from the start position to the destruction position and then is fixed at the destruction position. Fixing the contact member 237 at the destruction position prevents the substrate 500 from falling off the flavor inhaler 2. Furthermore, compared to a configuration in which the contact member 237 immediately returns to the start position, the amount of content remaining in the coating of the destroyed capsule 504 can be reduced.

[0040] Furthermore, the contact member 237 of the rupture mechanism 230 may be fixed at an intermediate position after moving from the start position to the rupture position. Fixing the contact member 237 at the intermediate position makes it possible to adjust the airflow resistance of the substrate 500. Also, it makes it possible to adjust the amount of the content of the capsule 504 released.

[0041] Furthermore, the contact member 237 of the destruction mechanism 230 may be fixed at an intermediate position selected by the user from among a plurality of intermediate positions after moving from the starting position to the destruction position. By fixing the contact member 237 at the intermediate position selected by the user, the airflow resistance desired by the user can be achieved. Furthermore, the flavor and aroma of the tobacco desired by the user can be imparted.

[0042] Furthermore, when moving from the start position to the destruction position, the contact member 237 of the destruction mechanism 230 may be fixed at an intermediate position between the start position and the destruction position. By fixing the contact member 237 at the intermediate position, it is possible to achieve the degree of destruction of the capsule 504 desired by the user.

[0043] Third Embodiment FIG. 10 is a diagram showing an example of a destruction mechanism 330 according to a third embodiment. FIG. 11 is an example of a cross-sectional view of a flavor inhaler 3 according to a third embodiment. FIG. 12 is another example of a cross-sectional view of a flavor inhaler 3 according to a third embodiment. Note that FIGS. 11 and 12 omit the internal configuration of the flavor inhaler 3, which is not normally visible to the user. FIG. 11 shows the connecting portion 235 shown in FIG. 6 in the start position, and FIG. 12 shows the connecting portion 235 in the destruction position. The flavor inhaler 3 according to the third embodiment differs from the flavor inhaler 1 according to the first embodiment in that the destruction mechanism 330 corresponds to the destruction mechanism 30. Differences from the first embodiment will be described below. The same components in the first and third embodiments are designated by the same reference numerals, and detailed descriptions thereof will be omitted.

[0044] 4 in that the destruction mechanism 330 shown in Fig. 10 is a mechanism that pushes the capsule region of the base material 500 based on the user's action in the center line direction, and destroys the capsules 504 arranged in the base material 500. Specifically, the destruction mechanism 330 is a swinging mechanism that swings the driven link 333 via the intermediate link 334 by the user sliding the drive link 331.

[0045] The destruction mechanism 330 has, for example, a drive link 331 that is moved in the centerline direction by the user, a driven link 333 that swings in accordance with the sliding movement of the drive link 331, a slide joint 332 that connects the drive link 331 and the driven link 333, and an intermediate link that is connected to the drive link 331 and the driven link 333. The drive link 331 is capable of moving in the centerline direction within the slide joint 332.

[0046] In the state shown in Fig. 11 , when the user slides the drive link 331 of the destruction mechanism 330 toward the first side, the drive link 331 moves toward the first side within the slide joint 332, and the driven link 333 swings via the intermediate link 334. A portion 335 connecting the driven link 333 and the intermediate link 334 (hereinafter referred to as the "connection portion") moves from the start position shown in Fig. 11 toward the inside of the flavor inhaler 1 as shown in Fig. 12. In other words, when the drive link 331 moves toward the first side within the slide joint 332, the connection portion 335, which is located adjacent to the internal space 141 and is movable into the internal space 141, moves from the start position shown in Fig. 11 into the internal space 141 as shown in Fig. 12. It is sufficient for the connection portion 335 to be movable to the destruction position, and it is preferable for the connection portion 335 to be movable to a position where all of the capsules 504 are destroyed by the connection portion 335.

[0047] When the user slides the drive link 331 toward the first side, the connecting portion 335 moves into the internal space 141, indirectly applying pressure to the capsule 504. The magnitude of this pressure is affected by the degree of movement of the drive link 331. The degree of movement of the drive link 331 can be adjusted based on the degree of sliding by the user. Note that if the connecting portion 335 includes a needle-shaped member, the needle-shaped member of the connecting portion 335 that has moved into the internal space 141 may penetrate the base material 500 and come into direct contact with the capsule 504, thereby destroying the capsule 504.

[0048] When the user releases the drive link 331, the drive link 331 extending from the flavor inhaler 3 slides toward the second side and moves within the slide joint 332 toward the second side. The connecting portion 335 also moves to the start position. Specifically, the connecting portion 335 moves from the start position to the destruction position and is then fixed at the start position. The movement of the drive link 331 may be maintained even when the user releases the drive link 331. Specifically, the slide joint 332 may be provided with a mechanism for locking the movement of the drive link 331. Even if the user releases the drive link 331 after the connecting portion 335 moves from the start position to the destruction position, the drive link 331 may be locked in a state where it is slid toward the second side, and the connecting portion 335 may be fixed at the destruction position. Alternatively, the slide joint 332 may be provided with a mechanism for gradually locking the movement of the drive link 331. Specifically, the connecting portion 335 may be fixed at an intermediate position between the start position and the destruction position, which is a position designated by the user.

[0049] As described above, the flavor inhaler 3 is a flavor inhaler that generates an aerosol by heating a substrate 500 having an aerosol source and a capsule 504 that releases its contents when broken, and includes a holding part 140 that forms an internal space 141 that accommodates and holds the substrate 500, and a destruction mechanism 330 that contacts a capsule region of the substrate 500 held in the holding part 140 where the capsules 504 are located. The destruction mechanism 330 pushes the capsule region from a start position where it starts moving to destroy the capsules 504, moves to a destruction position where it destroys the capsules 504, and is then fixed at a predetermined position. As with the flavor inhaler 1, the flavor inhaler 3 can control the position of the connection part 335 between the driven link 333 and the intermediate link 334 after the capsules 504 in the substrate 500 are destroyed.

[0050] <Fourth Embodiment> Fig. 13 is an example of a cross-sectional view of a flavor inhaler 4 according to a fourth embodiment. Fig. 14 is another example of a cross-sectional view of a flavor inhaler 4 according to a fourth embodiment. Note that Figs. 13 and 14 omit the internal configuration of the flavor inhaler 4, which is not normally visible to the user. Fig. 13 shows a state in which the contact member of the destruction mechanism 430 is in the start position, and Fig. 14 shows a state in which the contact member of the destruction mechanism 430 is in the destruction position. The flavor inhaler 4 according to the fourth embodiment differs from the flavor inhaler 1 according to the first embodiment in that the destruction mechanism 430 corresponds to the destruction mechanism 30. Differences from the first embodiment will be described below. The same reference numerals are used for the same components in the first and second embodiments, and detailed descriptions thereof will be omitted.

[0051] 13 differs from the destruction mechanism 30 shown in FIG. 4 in that the destruction mechanism 430 narrows the internal space 141 so as to press the capsule region of the substrate 500, thereby destroying the capsules 504 arranged in the substrate 500. Specifically, the destruction mechanism 430 is a mechanism that moves a contact member into the internal space 141 by a user operating a button (not shown), etc. Note that if the surface of the contact member that contacts the capsule region is needle-shaped, the needle of the contact member that has moved into the internal space 141 may penetrate the substrate 500 and come into direct contact with the capsules 504, thereby destroying the capsules 504.

[0052] The destruction mechanism 430 has a contact member that is stored in the main body 100 and can be moved into the internal space 141 by, for example, a user operating a button (not shown). Specifically, the destruction mechanism 430 moves from the start position shown in FIG. 13 into the internal space 141 as shown in FIG. 14 and is maintained in a state in which the internal space 141 is narrowed. Specifically, the contact member of the destruction mechanism 430 moves from the start position to the destruction position and is then fixed at the destruction position. Alternatively, the contact member of the destruction mechanism 430 may be fixed at an intermediate position between the start position and the destruction position. Furthermore, when the user releases a button operation (not shown), the contact member of the destruction mechanism 430 may be returned to the start position and fixed there.

[0053] As described above, the flavor inhaler 4 is a flavor inhaler that generates an aerosol by heating a substrate 500 having an aerosol source and a capsule 504 that releases its contents when broken, and includes a holding part 140 that forms an internal space 141 that accommodates and holds the substrate 500, and a destruction mechanism 430 that contacts a capsule region of the substrate 500 held in the holding part 140 where the capsules 504 are located. The destruction mechanism 430 pushes the capsule region from a start position where it starts moving to destroy the capsules 504, moves to a destruction position where it destroys the capsules 504, and is then fixed in a predetermined position. As with the flavor inhaler 1, the flavor inhaler 4 allows the position of the contact member of the destruction mechanism 430 to be controlled after destroying the capsules 504 in the substrate 500.

[0054] The flavor inhaler is not limited to the above-described configuration, and may be provided with candidate positions for fixing the contact member that contacts the capsule region included in the destruction mechanism. For example, the flavor inhaler may be provided with a button for accepting selection for each candidate, or a display unit that displays the candidates. When a user selects one candidate from multiple candidates, the contact member is fixed at the position of the selected candidate. This reduces the time it takes for the contact member to be fixed at the user's desired position. In addition, the flavor inhaler may be provided with candidate positions for the degree of capsule destruction or the degree of airflow resistance. For example, the position for fixing the contact member of the destruction mechanism may be automatically controlled based on the degree of capsule destruction or the degree of airflow resistance selected by the user. This makes it easy to impart a flavor flavor of a desired concentration or achieve a desired airflow resistance. In addition, the above-described embodiments may be combined, or the above-described embodiments may be combined with known techniques.

[0055] <Summary> The present disclosure includes the following configurations. (1) A flavor inhaler that generates an aerosol by heating a substrate having an aerosol source and a capsule that releases its contents when broken, comprising: a holding section that forms a space to accommodate and hold the substrate; and a contact member that contacts a capsule region of the substrate held in the holding section where the capsule is located, wherein the contact member moves from a first position where it starts moving to break the capsule to a second position where it pushes the capsule region to break the capsule, and then is fixed at a predetermined position. (2) The flavor inhaler described in (1), wherein the predetermined position is the first position. (3) The flavor inhaler described in (2), wherein the contact member moves to the second position and is fixed at the first position until a new substrate different from the substrate contacted by the contact member is held in the holding section. (4) The flavor inhaler described in (1), wherein the predetermined position is the second position. (5) The flavor inhaler according to (1), wherein the predetermined position is a third position located between the first position and the second position. (6) The flavor inhaler according to (5), wherein the predetermined position is a third position selected by a user from a plurality of third positions. (7) The flavor inhaler according to any of (1) to (6), wherein the contact member is fixed at a position between the first position and the second position when moving from the first position to the second position if the second position is the position to which the amount of displacement when moving from the first position is largest. (8) A flavor inhalation system comprising: the flavor inhaler according to any of (1) to (7); and a substrate having an aerosol source and a capsule that releases its contents when broken, the substrate being heated by the flavor inhaler.

[0056] 1, 2, 3, 4... flavor inhaler, 10... cover, 20... shutter, 30, 230, 330, 430... destruction mechanism, 33, 237... contact member, 100... main body, 140... holding part, 141... internal space, 500... base material, 504... capsule

Claims

1. A flavor inhaler that generates an aerosol by heating a substrate having an aerosol source and a capsule that releases its contents when broken, comprising: a holding section that forms a space for accommodating and holding the substrate; and a contact member that contacts a capsule region of the substrate held in the holding section in which the capsule is located, wherein the contact member moves from a first position where it starts to move to break the capsule to a second position where it pushes the capsule region and breaks the capsule, and is then fixed in a predetermined position.

2. The flavor inhaler according to claim 1, wherein the predetermined position is the first position.

3. The flavor inhaler according to claim 2, wherein after the contact member has moved to the second position, the contact member is fixed at the first position until a new substrate different from the substrate with which the contact member has come into contact is held in the holding portion.

4. The flavor inhaler according to claim 1, wherein the predetermined position is the second position.

5. The flavor inhaler according to claim 1, wherein the predetermined position is a third position located between the first position and the second position.

6. The flavor inhaler according to claim 5, wherein the predetermined position is a third position selected by a user from among a plurality of third positions.

7. A flavor inhaler as claimed in any one of claims 1 to 6, wherein, when the contact member moves from the first position to the second position, the contact member is fixed at a position between the first position and the second position, in a case where the second position is a position where the amount of displacement when moving from the first position is the largest.

8. A flavor inhalation system comprising: a flavor inhaler according to any one of claims 1 to 7; and a substrate having a capsule which releases its contents when broken and an aerosol source, the substrate being heated by the flavor inhaler.

Citation Information

Patent Citations

  • Receptacle Section

    JP2019528715A

  • Receptacle Section

    JP2019528717A

  • A device for generating aerosols

    JP2021531026A

  • Inhaling device, control method, and program

    WO2021260894A1